- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.03. | WHO directs antibiotic development to priority pathogens | ||
| 13.03. | PRISM BioLab partners with Receptor.AI for molecule discovery | ||
| 13.03. | PsiQuantum and National Cancer Center Japan partner on quantum computing | ||
| 12.03. | Vima banks $100m in Series A to progress Parkinson's drug | ||
| 12.03. | Eli Lilly finds impurity in compounded tirzepatide | ||
| 12.03. | Bavarian Nordic and SII sign agreement for chikungunya vaccine production | ||
| 12.03. | Curatis and Neupharma sign development agreement for corticorelin in Japan | ||
| 11.03. | FDA issues warning to Novo Nordisk on unreported semaglutide safety events | ||
| 11.03. | Eli Lilly to invest $3bn in China in anticipation of orforglipron approval | ||
| 11.03. | BioNTech co-founders step down to launch new mRNA venture | ||
| 11.03. | UK health authorities join forces to champion foreign infectious disease trials | ||
| 11.03. | Idorsia and Pharmalink sign agreement to distribute Quviviq | ||
| 11.03. | FDA approves GSK's Wellcovorin for cerebral folate deficiency | ||
| 10.03. | FDA homes in on biosimilar accessibility in new draft guidance | ||
| 10.03. | Junshi receives China's NMPA acceptance for toripalimab injection | ||
| 10.03. | Novo and Hims & Hers become partners to end legal feud | ||
| 10.03. | NewcelX and Eledon partner for NCEL-101 programme | ||
| 09.03. | GSK sells liver disease drug candidate to Alfasigma for $690m | ||
| 09.03. | Vinay Prasad to leave the FDA again | ||
| 09.03. | Sciwind secures China's NMPA approval for Ecnoglutide injection | ||
| 09.03. | BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment | ||
| 06.03. | Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal | ||
| 06.03. | J&J announces Tecvayli-Darzalex combo approval from FDA for multiple myeloma | ||
| 06.03. | Liberate Bio gains licences for myeloid-specific CAR design patents | ||
| 05.03. | Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.